SANOFI and GSK APPROVED TO COVID VACCINE CANDIDATE
French drugmaker Sanofi and its British partner GlaxoSmithKline are seeking regulatory approval for their COVID-19 vaccine to be used as a booster, as well as a standalone two-dose shot, after several setbacks. The companies said on Wednesday they intended to submit data to regulators from a late-stage trial of the vaccine, and another testing it […]
Continue Reading